Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Fire needle acupuncture is effective for treating alopecia areata.

PRP injections significantly improve hair regrowth in alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Triamcinolone acetonide and betamethasone 1.75 mg/ml are both effective for treating alopecia areata.

Oral cyclosporine is an effective and safe treatment for severe alopecia areata.

Dermatologists often treat alopecia areata inconsistently, especially in children and advanced cases.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

PRP injections are a simple, safe, and cost-effective treatment for hair loss.

Low level laser therapy effectively treats alopecia areata on the scalp.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

Hemp seed oil shows promise in treating localized alopecia areata.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

Farudodstat may effectively treat alopecia areata without harming hair follicles.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

More research is needed to find the best long-term treatments for Alopecia Areata.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Method B with propylene glycol is better for stable low-concentration DPCP solutions for alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Baricitinib is effective and safe for treating severe alopecia areata.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.